Digital Diagnostics
About Digital Diagnostics
Digital Diagnostics is a pioneering healthcare technology company that develops and implements artificial intelligence (AI) systems to diagnose diseases by analyzing high-quality images. Their mission is to enhance the accessibility, affordability, and quality of healthcare globally by creating technology that benefits patients. The company is recognized for developing the first FDA-cleared autonomous AI diagnostic platform, LumineticsCore® (formerly IDx-DR), which can make clinical decisions without human intervention. This platform is designed to detect diabetic retinopathy, including diabetic macular edema, at the point-of-care, aiming to increase patient access to care and expedite referrals for specialist treatment when needed.
Digital Diagnostics emphasizes an ethical approach to AI in healthcare, working with regulators, providers, and patient advocacy groups to establish AI diagnosis as a new standard of care. Their autonomous systems are intended to remove the diagnostic burden of common diseases from specialists, allowing for improved patient outcomes through precise and affordable disease diagnosis. Beyond diabetic retinopathy, the company is actively researching additional applications for AI-based diagnostic solutions using fundus imaging, including exploring glaucoma, cardiovascular indications, age-related macular degeneration (AMD), and neurodegenerative indications. They also offer SphereDx, a secure data platform that integrates with LumineticsCore for centralized access to exam results and real-time monitoring of key performance metrics.
Focus Areas
Business Intelligence
| Technology | AI-based diagnostic platform, autonomous AI algorithms, biomarker-based approach, deep learning, computer vision for medical imaging, cloud-based clinical result platforms, EHR interoperability |
What Physicians Need to Know
For physicians, Digital Diagnostics' LumineticsCore® offers a significant opportunity to streamline diabetic retinopathy screening by providing autonomous diagnostic results at the point-of-care. This can increase patient compliance with annual eye exams for diabetes, close HEDIS and MIPS care gaps, and allow for immediate actionable next steps. The system can free up specialists by autonomously diagnosing common conditions, enabling them to focus on more complex cases. The availability of a CPT® Category I code (92229) ensures reimbursement for the service. Physicians can leverage this technology to improve patient outcomes through early detection, especially in underserved populations, and enhance overall clinic productivity.
Digital Diagnostics' systems are designed for EHR integration, facilitating seamless workflow within existing healthcare infrastructures. The use of cloud-based platforms in digital diagnostics generally enables secure storage of patient records, collaboration between specialists, and faster access to imaging, simplifying integration between diagnostic equipment and electronic health records. Their technology is indicated for use with specific imaging devices, such as the Topcon TRC-NW400 camera for LumineticsCore®.
What the Web Says
Digital Diagnostics is a healthcare AI company that develops autonomous diagnostic systems. Their flagship product, LumineticsCore®, is an AI system designed to diagnose diabetic retinopathy without requiring a physician to interpret the images, aiming to increase access to care and improve patient outcomes. They have also been involved in pioneering FDA-cleared digital cytology systems for cervical cancer screening, which combine AI with advanced imaging to assist in identifying precancerous lesions and cancer cells. Employer reviews indicate a mixed sentiment regarding work-life balance, pay, and management, with some positive experiences and some concerns about negative work culture and changing strategic decisions.
Overall: MixedStrengths
- AI-powered diagnostic systems enhance accuracy and efficiency in disease detection.
- Increases patient access to specialized care by providing point-of-care diagnostics.
- Reduces the burden on specialists for common disease diagnoses.
- Potential to improve patient outcomes through earlier and more precise diagnosis.
- Pioneering in establishing AI diagnosis as a new standard of care, including FDA clearance and CPT codes.
- Some employees have found it a great place to learn management skills and enjoyed the work environment.
Limitations
- Some employer reviews mention a negative work culture.
- Upper management may not always understand quality regulations and the importance of quality in medical devices.
- Goals, objectives, and strategic decisions are frequently changing, which can lead to wasted effort.
- Concerns about job security and advancement opportunities have been raised by employees.
- One review mentioned disorganized promotion processes with signs of discrimination.
- Lack of dental plan according to one employee review.
Based on reviews from: Indeed.com, Elion Health, Clinical Pathology Laboratories, SelectScience, Hologic, Digital Diagnostics (company website), Reddit, PitchBook
Last updated: 2026-10-26
Videos
News, demos, and interviews about Digital Diagnostics.
Videos load interactively. If none appear, search YouTube for Digital Diagnostics →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Digital Diagnostics.
Related Companies
RetiVue is a healthcare AI company specializing in novel widefield retinal camera technology and eye care cloud services. Their mission is to prevent blindness in underserved and medically at-risk populations by providing affordable, high-definition retinal imaging solutions. The company’s flagship product, the EntireEye Imaging System, offers non-contact, non-mydriatic, high-definition image capture with up to a […]
AI Optics is a healthcare AI company dedicated to transforming point-of-care diagnostics through innovative AI-powered retinal screening technology. The company develops portable hardware and AI-based software to bring eye screening out of specialist offices and into primary care and retail health settings, aiming to increase access to eye screening and empower healthcare professionals to make […]
Thirona is a Dutch MedTech company specializing in artificial intelligence (AI) for advanced medical image analysis, primarily focusing on thoracic CT scans, chest X-rays, and retinal images. Founded by scientists Eva van Rikxoort and Bram van Ginneken from the Radboud University Medical Center, Thirona aims to bridge the gap between academic advancements in medical image […]
Google Health, an initiative (formerly a division) of Google, aims to leverage Google’s technology, particularly AI, to improve health outcomes globally. The company focuses on developing AI-powered tools and products to enhance the efficiency of healthcare workflows, reduce administrative burdens, accelerate innovation, and decrease costs. For physicians, this translates to tools like Google Care Studio, […]
Optivate is a healthcare AI company that provides a unified ophthalmology EHR platform designed to streamline workflows, reduce administrative burden, and improve patient care. The platform is purpose-built for ophthalmology and eye care practices, rather than being adapted from generic or multi-specialty systems. It integrates clinical care, practice management, revenue cycle, patient engagement, and optical […]
Orbis International is a global non-profit organization dedicated to preventing blindness and treating blinding eye diseases in low- and middle-income countries. They achieve this through a multi-faceted approach that includes hands-on training, public health education, advocacy, and local partnerships. A cornerstone of their work is the Flying Eye Hospital, a fully accredited ophthalmic teaching hospital […]